Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation

[1]  Nazneen Rahman,et al.  OpEx - a validated, automated pipeline optimised for clinical exome sequence analysis , 2016, Scientific Reports.

[2]  R. Poon,et al.  TRIP13 Regulates Both the Activation and Inactivation of the Spindle-Assembly Checkpoint. , 2016, Cell reports.

[3]  Christian R. Nelson,et al.  TRIP13PCH-2 promotes Mad2 localization to unattached kinetochores in the spindle checkpoint response , 2015, The Journal of cell biology.

[4]  C. Shaw,et al.  Mutations in the transcriptional repressor REST predispose to Wilms tumor , 2015, Nature Genetics.

[5]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[6]  S. Seal,et al.  The ICR1000 UK exome series: a resource of gene variation in an outbred population , 2015, F1000Research.

[7]  Nazneen Rahman,et al.  CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting , 2015, Genome Medicine.

[8]  Hans Clevers,et al.  Sequential cancer mutations in cultured human intestinal stem cells , 2015, Nature.

[9]  A. Moeller,et al.  TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching , 2015, eLife.

[10]  G. Vader.  Pch2TRIP13: controlling cell division through regulation of HORMA domains , 2015, Chromosoma.

[11]  A. Hershko,et al.  Disassembly of mitotic checkpoint complexes by the joint action of the AAA-ATPase TRIP13 and p31comet , 2014, Proceedings of the National Academy of Sciences.

[12]  G. McVean,et al.  Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications , 2014, Nature Genetics.

[13]  G. Chan,et al.  Thyroid Hormone Receptor Interacting Protein 13 (TRIP13) AAA-ATPase Is a Novel Mitotic Checkpoint-silencing Protein* , 2014, The Journal of Biological Chemistry.

[14]  J. V. van Deursen,et al.  Aneuploidy in health, disease, and aging , 2013, The Journal of cell biology.

[15]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[16]  B. Snel,et al.  Evolution and function of the mitotic checkpoint. , 2012, Developmental cell.

[17]  Martin Goodson,et al.  Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. , 2011, Genome research.

[18]  D. Gisselsson,et al.  Mutations in CEP57 cause mosaic variegated aneuploidy syndrome , 2011, Nature Genetics.

[19]  D. Compton,et al.  Mechanisms of Chromosomal Instability , 2010, Current Biology.

[20]  D. Cleveland,et al.  Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis , 2009, Nature Reviews Molecular Cell Biology.

[21]  D. G. Gibson,et al.  Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.

[22]  P. Barros-Núñez,et al.  Clinical and genetic heterogeneity in patients with mosaic variegated aneuploidy: Delineation of clinical subtypes , 2008, American journal of medical genetics. Part A.

[23]  Angelika Amon,et al.  Aneuploidy: Cells Losing Their Balance , 2008, Genetics.

[24]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[25]  N. Rahman,et al.  Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B , 2004, Nature Genetics.

[26]  S. Jacquemont,et al.  High risk of malignancy in mosaic variegated aneuploidy syndrome. , 2002, American journal of medical genetics.

[27]  K. Yokomori,et al.  Cancer-prone syndrome of mosaic variegated aneuploidy and total premature chromatid separation: report of five infants. , 2001, American journal of medical genetics.

[28]  K. Anyane-Yeboa,et al.  Mosaic variegated aneuploidy with microcephaly: a new human mitotic mutant? , 1991, Annales de genetique.